PlainPharmaWatch

CMS Open Payments · Tool

Innova Vascular Inc. vs ICU Medical Inc

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Innova Vascular Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 4,911, versus 3,209 for the other company. Its single largest recorded recipient represents 68.7% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Innova Vascular Inc.
HHI 4,911 · top recipient 68.7%
Ranked #377 of 1,838 companies by HHI
ICU Medical Inc
HHI 3,209 · top recipient 48.1%
Ranked #544 of 1,838 companies by HHI

Payment Overview

Total Payments
$57.1K
% of Industry
0.0%
Transactions
30
Avg per Transaction
$1.9K
Recipients
28
Avg per Recipient
$2.0K
Payment Types
3
Top Payment Type
Travel and Lodging
Company B

ICU Medical Inc

Total Payments
$55.8K
% of Industry
0.0%
Transactions
117
Avg per Transaction
$476.62
Recipients
117
Avg per Recipient
$476.62
Payment Types
6
Top Payment Type
Grant

Highlighted values indicate the higher figure for each metric.

Total payments compared

Innova Vascular Inc. vs ICU Medical Inc - total reported payments in CMS Open Payments PY2024

Innova Vascular Inc.$57.1KICU Medical Inc$55.8K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Innova Vascular Inc.

Travel and Lodging $7.6K

68.4%

Food and Beverage $2.2K

20.2%

Consulting Fee $1.3K

11.3%

ICU Medical Inc

Grant $41.8K

75.0%

Compensation for Faculty or Speaker (Medical Education) $5.0K

9.0%

Consulting Fee $5.0K

9.0%

Food and Beverage $2.7K

4.9%

Space Rental or Facility Fees $1.0K

1.8%

Travel and Lodging $236.20

0.4%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Innova Vascular Inc.

  1. 1

    SANTHOSH MATHEWS

    $7,591.10 · 9 txns

  2. 2

    BHAVRAJ KHALSA

    $1,426.10 · 3 txns

  3. 3

    BASHIR AKHAVAN TAFTI

    $290.00 · 1 txns

  4. 4

    KEVIN BURNS

    $176.10 · 1 txns

  5. 5

    WILLIAM KEELING

    $159.87 · 1 txns

ICU Medical Inc

  1. 1

    Mayo Clinic Florida

    $26,816.00 · 2 txns

  2. 2

    Mayo Clinic Hospital Rochester

    $15,000.00 · 1 txns

  3. 3

    Jung Kim

    $5,236.20 · 2 txns

  4. 4

    Daniel L. Croteau

    $5,034.20 · 4 txns

  5. 5

    University Of Iowa Hosp & Clinics

    $1,000.00 · 1 txns

Summary Comparison

Metric Innova Vascular Inc. ICU Medical Inc
Total Payments $57.1K $55.8K
% of Industry Total 0.0% 0.0%
Transaction Count 30 117
Avg per Transaction $1.9K $476.62
Recipient Count 28 117
Avg per Recipient $2.0K $476.62
Payment Type Count 3 6
Top Payment Type Travel and Lodging Grant

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.